| |
|
|
|
Alpine Immune Sciences Inc  
|
|
9.37 0 (0%) |
08-14 16:00 |
|
Open: |
9.38 |
Pre close: |
9.37 |
Target:
|
12.54
|
|
High: |
9.49 |
Low: |
9.25 |
Resistance:
|
10.74
11.94
|
|
Volume: |
61,609 |
Market Cap: |
223M |
Support:
|
8.80
7.32
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
9.71
 |
MACD |
MACD(12,26):
|
0.17 |
|
MA(20): |
10.26 |
Signal(12,26,9): |
0.43 |
|
MA(100): |
6.06  |
Stochastic Oscillator |
%K(14,3):
|
10.66 |
|
MA(250): |
4.46 |
%D(3): |
16.85 |
|
Average Volume(K) |
3-Month: |
88683
|
52-Week |
High:
|
15.00 |
|
10-Days: |
8639 |
Low: |
2.05 |
|
RSI |
RSI(14):
|
45.29 |
Change(%): |
95.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.880 |
Return on Equity (ttm) |
-86.0 |
Shares Out. (M) |
18.59 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-39.0 |
Shares Float (M) |
3.90 |
|
EPS Est. Next Year |
-2.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
40.52 |
|
EPS Est. Next Quarter |
-1.030 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
44.39 |
|
Forward EPS |
-2.280 |
Gross Profit (p.s.) |
-1.835 |
Shares Short (K) |
45 |
|
Book Value (p.s.) |
1.340 |
EBITDA (p.s.) |
-1.945 |
P/E |
-4.98 |
|
Sales Per Share |
0.152 |
Qtrly Earnings Growth |
0.00 |
P/BV |
6.99 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-33.82 |
P/S |
61.55 |
|
Operating Margin |
-1287.32 |
Levered Free Cash Flow
(M) |
-24.42 |
P/CF |
-5.15 |
|
|
|
|
|
|
